Merck reported a 2% decline in Gardasil sales, after reaching a peak of $8.9 billion in 2023. Now with shipments to China paused, the HPV vaccine faces significant headwinds going into 2025.

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

There's no question about it, McDonald's is the most successful restaurant in the history of the world. The company isn't ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best depressed stocks ...

HPV vaccines aim to prevent the development of HPV-related cancers by stopping the viral infection from taking hold in the ...

The daughter of US president John F. Kennedy has denounced her cousin, Robert Kennedy Jr, as a “predator” who is “addicted to attention and power”. This means awkward silences around the dinner table ...

Earnings estimates for Merck for 2025 have declined from $9.57 to $9.44 per share over the ... to have been driven by cancer drug Keytruda, like in the previous quarters, backed by additional ...

Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug ... % in the past year compared with a decline of 3.9% for the industry. Merck MRK stock has declined ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...